Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature

Experimental Hematology

Volumn 34, Issue 11, 2006, Pages 1443-1450

  Jacoub, Jack F ^a   Suryadevara, Uma ^a   Pereyra, Vivian ^a   Colón, Donna ^a   Fontelonga, Antonio ^a   MacKintosh, F Roy ^a   Hall, Stephen W ^a   Ascensão, João L ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOPHOSPHAMIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NARCOTIC ANALGESIC AGENT; PACLITAXEL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; AGED; APHERESIS; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLEEDING; BONE PAIN; BREAST CANCER; CANCER CHEMOTHERAPY; CATHETER INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG COST; DRUG FATALITY; DRUG HYPERSENSITIVITY; FEBRILE NEUTROPENIA; FEMALE; HEART DISEASE; HODGKIN DISEASE; HUMAN; LEUKAPHERESIS; MALE; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; MYALGIA; OVARY CANCER; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL MOBILIZATION; THERAPY DELAY; THROMBOCYTOPENIA; UROGENITAL TRACT DISEASE; VASCULAR ACCESS;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM STAGING; OVARIAN NEOPLASMS; PILOT PROJECTS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 33749998568     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.06.022     Document Type: Review

References (43)

1. Rowley S.D. Practical aspects of stem cell collection. In: Hoffman R., Benz Jr. E., Shattil S., et al. (Eds). Hematology: Basic Principles and Practice. Third Edition (2000), New York, NY: Churchill Livingstone 1642-1658
2. Tricot G., Jagannath S., Vesole D., et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 85 (1995) 588-596
3. Siena S., Schiavo R., Pedrazzoli P., and Carlo-Stella C. Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy. J Clin Oncol 18 (2000) 1360-1377
4. Weaver C.H., Hazelton B., Birch R., et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 86 (1995) 3961-3969
5. Morris C.L., Siegel E., Barlogie B., et al. Mobilization of CD34+ cells in elderly patients (>/= 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen. Br J Haematol 120 (2003) 413-423
6. Haas R., Mohle R., Fruhauf S., et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83 (1994) 3787-3794
7. Ketterer N., Salles G., Moullet I., et al. Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies. Br J Haematol 103 (1998) 235-242
8. Cottler-Fox M.H., Lapidot T., Petit I., et al. Stem cell mobilization. Hematology (Am Soc Hematol Educ Program) 1 (2003) 419-437
9. Tarella C., Caracciolo D., Gavarotti P., et al. Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilization. Bone Marrow Transplant 16 (1995) 223-228
10. Ford C.D., Lehman C., Strupp A., and Kelley L. Comparison of CD34+ cell collection efficiency on the COBE Spectra and Fenwal CS-3000 Plus. J Clin Apher 17 (2002) 17-20
11. Bojko P., Scharifi M., Stossel K., and Seeber S. Comparison of processing four and five times the patients' blood volume during peripheral blood stem cell collection and analysis of CD34+38- and CD34+49d+ subsets during apheresis. J Cancer Res Clin Oncol 128 (2002) 19-28
12. Bensinger W., Appelbaum F., Rowley S., et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 13 (1995) 2547-2555
13. Weaver C.H., Schulman K.A., and Buckner C.D. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim. Bone Marrow Transplant 27 Suppl 2 (2001) S23-S29
14. Schwartzberg L.S., Birch R., Hazelton B., et al. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor. J Hematother 1 (1992) 317-327
15. Van Hoef M.E. Haematological recovery after high-dose consolidation chemotherapy with peripheral blood progenitor cell rescue: the effects of the mobilization regimen and post-transplant growth factors. Neth J Med 52 (1998) 30-39
16. To L.B., Haylock D.N., Simmons P.J., and Juttner C.A. The biology and clinical uses of blood stem cells. Blood 89 (1997) 2233-2258
17. Bengala C., Fennelly D., Shapiro F., et al. Taxol in combination with cyclophosphamide and G-CSF can improve the mobilization of peripheral blood progenitor cells (PBPCs) in untreated locally advanced ovarian cancer: preliminary report. Blood 82 Suppl 1 (1993) 82 (abstract 318)
18. Fennelly D., Bengala C., Schneider J., et al. Peripheral blood progenitor mobilization using Taxol in combination with cyclophosphamide and G-CSF: quantitation and correlation of CD34+ cell count, colony-forming-unit-granulocyte-macrophage (CFU-GM) and mononuclear cell count. Blood 84 Suppl 1 (1994) 105 (abstract 409)
19. Sutherland D.R., Keating A., Nayar R., Anania S., and Stewart A.K. Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol 22 (1994) 1003-1010
20. Demirer T., Buckner C.D., Storer B., et al. Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor. J Clin Oncol 16 (1998) 1547-1553
21. Weaver C.H., Schwartzberg L.S., Zhen B., et al. Mobilization of peripheral blood stem cells with docetaxel and cyclophosphamide (CY) in patients with metastatic breast cancer: a randomized trial of 3 vs 4 g/m2 of CY. Bone Marrow Transplant 23 (1999) 421-425
22. Klein J., Rey P., Dansey R., et al. Cyclophosphamide and paclitaxel as initial or salvage regimen for the mobilization of peripheral blood progenitor cells. Bone Marrow Transplant 24 (1999) 959-963
23. Demirer T., Rowley S., Buckner C.D., et al. Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer. J Clin Oncol 13 (1995) 1714-1719
24. Weaver C.H., Schwartzberg L.S., Birch R., et al. Collection of peripheral blood stem cells following administration of paclitaxel, cyclophosphamide, and filgrastim in patients with breast and ovarian cancer. Biol Blood Marrow Transplant 3 (1997) 83-90
25. Haynes A., Hunter A., McQuaker G., Anderson S., Bienz N., and Russell N.H. Engraftment characteristics of peripheral blood stem cells mobilised with cyclophosphamide and the delayed addition of G-CSF. Bone Marrow Transplant 16 (1995) 359-363
26. McQuaker I., Haynes A., Stainer C., Byrne J., and Russell N. Mobilisation of peripheral blood stem cells with IVE and G-CSF improves CD34+ cell yields and engraftment in patients with non-Hodgkin's lymphomas and Hodgkin's disease. Bone Marrow Transplant 24 (1999) 715-722
27. Lerro K.A., Medoff E., Wu Y., et al. A simplified approach to stem cell mobilization in multiple myeloma patients not previously treated with alkylating agents. Bone Marrow Transplant 32 (2003) 1113-1117
28. Laport G.G., Fleming G.F., Waggoner S., Zimmerman T.M., Grinblatt D.L., and Williams S.F. A phase II trial of docetaxel for peripheral blood stem cell mobilization for patients with breast cancer and ovarian cancer. Bone Marrow Transplant 27 (2001) 677-681
29. Arpaci F., Komurcu S., Ozturk B., Ozet A., Kinalp C., and Yalcin A. The mobilization with delayed G-CSF administration after standard induction chemotherapy and single standard volume apheresis can supply adequate amount of CD34(+) cells in patients with breast cancer. Haematologica 86 (2001) E01
30. Bargetzi M.J., Passweg J., Baertschi E., et al. Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective. Bone Marrow Transplant 31 (2003) 99-103
31. Lefrere F., Audat F., Hermine O., et al. The timing of granulocyte-colony-stimulating factor administration after chemotherapy does not affect stem and progenitor cell apheresis yield: a retrospective study of 65 cases. Transfusion 39 (1999) 561-564
32. Min Y.J., Kim S.W., Suh C., et al. The possible cost effectiveness of peripheral blood stem cell mobilization with cyclophosphamide and the late addition of G-CSF. J Korean Med Sci 15 (2000) 49-52
33. Dolgopolov I., Andreeva L., Yankelevich M., Mscheidze D., Siegel S., and Mentkevich G. Delayed introduction of G-CSF after chemotherapy does not affect peripheral blood stem cell yield and engraftment kinetics in children with high-risk malignancies: retrospective study of 45 cases. Am J Hematol 73 (2003) 225-229
34. Stewart D.A., Guo D., Morris D., et al. Superior autologous blood stem cell mobilization from dose-intensive cyclophosphamide, etoposide, cisplatin plus G-CSF than from less intensive chemotherapy regimens. Bone Marrow Transplant 23 (1999) 111-117
35. Benet I., Prosper B.F., Marugan I., et al. Mobilization of peripheral blood progenitor cells (PBPC) in patients undergoing chemotherapy followed by autologous peripheral blood stem cell transplant (SCT) for high risk breast cancer (HRBC). Bone Marrow Transplant 23 (1999) 1101-1107
36. Weaver C.H., Birch R., Greco F.A., et al. Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim. Br J Haematol 100 (1998) 338-347
37. Demirer T., Ayli M., Ozcan M., et al. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF. Br J Haematol 116 (2002) 468-474
38. Lefrere F., Belanger C., Audat F., et al. The dose of granulocyte-colony-stimulating factor after chemopriming treatment does not influence apheresis yield of progenitor cells: a retrospective study of 91 cases. Transfusion 39 (1999) 1207-1211
39. 2) after salvage chemotherapy for lymphoma. Bone Marrow Transplant 20 (1997) 855-858
40. Desikan K.R., Jagannath S., Siegel D., et al. Collection of more hematopoietic progenitor cells with large volume leukapheresis in patients with multiple myeloma. Leuk Lymphoma 28 (1998) 501-508
41. Comenzo R.L., Malachowski M.E., Miller K.B., et al. Large-volume leukapheresis for collection of mononuclear cells for hematopoietic rescue in Hodgkin's disease. Transfusion 35 (1995) 42-45
42. Smolowicz A.G., Villman K., and Tidefelt U. Large-volume apheresis for the harvest of peripheral blood progenitor cells for autologous transplantation. Transfusion 37 (1997) 188-192
43. Humpe A., Riggert J., Munzel U., et al. A prospective, randomized, sequential, crossover trial of large-volume versus normal-volume leukapheresis procedures: effect on progenitor cells and engraftment. Transfusion 39 (1999) 1120-1127